Hillhouse Investment Group

Hillhouse Investment Group, founded in 2005 and headquartered in Hong Kong, is a private equity firm that specializes in a wide range of investments, from seed funding to buyouts and listed equities. The firm primarily focuses on opportunities in Asia but also selectively invests in North America and Europe. Hillhouse’s investment strategy is stage-agnostic, allowing it to invest in companies at various stages of growth, from startups to established public entities. Its portfolio spans several sectors, including consumer, technology, media, telecommunications, healthcare, energy transition, and advanced manufacturing. In healthcare, Hillhouse emphasizes biotechnology, medical devices, and pharmaceuticals. The firm is recognized for its commitment to independent research and employs sector experts to guide its investment decisions, aiming for long-term results rather than short-term gains.

David Rhee

Partner

Michael Yi

Partner

Past deals in Hong Kong

Harmay

Series D in 2022
Beijing Harmay Lexiang Technology Co., Ltd. manufactures and sells cosmetics and skin care products. The company distributes skin and beauty care products of other brands, such as ICONIC LONDON, dermalogica, BOTANIST, and SG79|STHLM. It sells its products through its stores in Shanghai, Beijing, and Chengdu, China; and Hong Kong. Beijing Harmay Lexiang Technology Co., Ltd. was founded in 2013 and is based in Beijing, China.

Great Bay Bio

Series A in 2021
Great Bay Bio Ltd. engages in research and development for drug discovery and provides contract research services by applying AI technology on CMC (Chemistry, Manufacturing, Control) platform for drug development. The company also engages in research, development, and manufacturing protein sequence products, including recombinant insulin-stimulating hormone and fusion protein. The company was founded in 2002 and is based in Central, Hong Kong.

Innocare

Post in 2021
InnoCare Pharma Limited is a biopharmaceutical company focused on developing innovative treatments for cancer and autoimmune diseases. Founded in 2015 and headquartered in Wanchai, Hong Kong, InnoCare operates additional offices in major cities across China and in Cambridge, Massachusetts. The company is advancing several clinical programs, including Orelabrutinib, which targets various B-cell malignancies and is currently undergoing registrational trials. It is also developing ICP-192, a pan-inhibitor of fibroblast growth factor receptor, and ICP-105, which targets FGFR4 in advanced hepatocellular carcinoma. InnoCare's preclinical pipeline includes promising candidates aimed at treating specific cancer types and autoimmune disorders. The firm is supported by a highly qualified scientific team and a specialized advisory board, reinforcing its commitment to pushing the boundaries of drug innovation and improving patient outcomes.

Lalamove

Series F in 2021
Lalamove, originally known as EasyVan, was established in Hong Kong in December 2013 to address the demand for efficient van hire services. The company operates in 21 markets across Asia and Latin America, connecting over 7 million customers with a network of more than 700,000 driver-partners. Lalamove's on-demand logistics platform facilitates instant matching between customers and drivers, enabling same-day deliveries with an impressive average fulfillment time of just 55 minutes. The platform offers van-hailing and courier services, allowing customers to track their deliveries in real time and rate their drivers. By optimizing routes and fleets, Lalamove enhances the earning potential for drivers while providing reliable and swift delivery solutions for businesses and individuals alike.

Lalamove

Series E in 2020
Lalamove, originally known as EasyVan, was established in Hong Kong in December 2013 to address the demand for efficient van hire services. The company operates in 21 markets across Asia and Latin America, connecting over 7 million customers with a network of more than 700,000 driver-partners. Lalamove's on-demand logistics platform facilitates instant matching between customers and drivers, enabling same-day deliveries with an impressive average fulfillment time of just 55 minutes. The platform offers van-hailing and courier services, allowing customers to track their deliveries in real time and rate their drivers. By optimizing routes and fleets, Lalamove enhances the earning potential for drivers while providing reliable and swift delivery solutions for businesses and individuals alike.

Zhaoke Ophthalmology Pharmaceutical

Series B in 2020
Zhaoke Ophthalmology Pharmaceutical is a Pharmaceutical platform.

Airwallex

Series D in 2020
Airwallex is a technology company based in Hong Kong that specializes in providing a global payments and financial platform. Its services facilitate international transactions for businesses of all sizes, allowing them to make and receive payments efficiently and cost-effectively. By integrating advanced technology with a comprehensive ecosystem of application programming interfaces, Airwallex streamlines financial processes, enabling clients to issue and pay invoices in their preferred currency at competitive exchange rates. The platform addresses the complexities of the traditional financial system, helping businesses save time and reduce costs while expanding their operations both domestically and internationally. With a focus on empowering companies to thrive in a borderless digital economy, Airwallex plays a significant role in enhancing global commerce.

Harmay

Series A in 2019
Beijing Harmay Lexiang Technology Co., Ltd. manufactures and sells cosmetics and skin care products. The company distributes skin and beauty care products of other brands, such as ICONIC LONDON, dermalogica, BOTANIST, and SG79|STHLM. It sells its products through its stores in Shanghai, Beijing, and Chengdu, China; and Hong Kong. Beijing Harmay Lexiang Technology Co., Ltd. was founded in 2013 and is based in Beijing, China.
Aier Eye Hospital Group operates a network of ophthalmic hospitals and institutions, specializing in comprehensive eye care services. Founded in 2003 and headquartered in Changsha, China, the group manages approximately 200 hospitals in mainland China, along with facilities in Europe, the United States, and Hong Kong. The company focuses on various aspects of eye health, including diagnosis and treatment of fundus diseases, glaucoma, cataracts, and pediatric ophthalmology. It also provides optometry services, myopia surgery, and aesthetic eye shaping treatments. Aier Eye Hospital Group is dedicated to high-standard medical care and offers training courses aimed at cataract prevention and treatment.

Airwallex

Series C in 2019
Airwallex is a technology company based in Hong Kong that specializes in providing a global payments and financial platform. Its services facilitate international transactions for businesses of all sizes, allowing them to make and receive payments efficiently and cost-effectively. By integrating advanced technology with a comprehensive ecosystem of application programming interfaces, Airwallex streamlines financial processes, enabling clients to issue and pay invoices in their preferred currency at competitive exchange rates. The platform addresses the complexities of the traditional financial system, helping businesses save time and reduce costs while expanding their operations both domestically and internationally. With a focus on empowering companies to thrive in a borderless digital economy, Airwallex plays a significant role in enhancing global commerce.

Lalamove

Series D in 2019
Lalamove, originally known as EasyVan, was established in Hong Kong in December 2013 to address the demand for efficient van hire services. The company operates in 21 markets across Asia and Latin America, connecting over 7 million customers with a network of more than 700,000 driver-partners. Lalamove's on-demand logistics platform facilitates instant matching between customers and drivers, enabling same-day deliveries with an impressive average fulfillment time of just 55 minutes. The platform offers van-hailing and courier services, allowing customers to track their deliveries in real time and rate their drivers. By optimizing routes and fleets, Lalamove enhances the earning potential for drivers while providing reliable and swift delivery solutions for businesses and individuals alike.

Airwallex

Series B in 2018
Airwallex is a technology company based in Hong Kong that specializes in providing a global payments and financial platform. Its services facilitate international transactions for businesses of all sizes, allowing them to make and receive payments efficiently and cost-effectively. By integrating advanced technology with a comprehensive ecosystem of application programming interfaces, Airwallex streamlines financial processes, enabling clients to issue and pay invoices in their preferred currency at competitive exchange rates. The platform addresses the complexities of the traditional financial system, helping businesses save time and reduce costs while expanding their operations both domestically and internationally. With a focus on empowering companies to thrive in a borderless digital economy, Airwallex plays a significant role in enhancing global commerce.

Nio

Series C in 2017
Nio Limited is a prominent electric vehicle manufacturer based in Shanghai, China, focusing on the premium segment of the market. Founded in 2014, the company designs, jointly manufactures, and sells smart electric vehicles, including five, six, and seven-seater SUVs. Nio is recognized for its innovative technology, including battery swapping and autonomous driving features, which enhance user experience. Its model lineup includes the ES8, a high-performance seven-seater SUV launched in 2018, the ES6 five-seater SUV, and the EC6 electric coupe SUV. The company also provides a range of charging solutions, such as home charging, battery swapping services, and mobile charging options, alongside value-added services like insurance and maintenance. In addition to its electric vehicle offerings, Nio collaborates with organizations like Mobileye N.V. to advance its technology. As of 2023, Nio has sold over 160,000 electric vehicles, capturing approximately 2% of the new energy vehicle market in China.

Nio

Series B in 2016
Nio Limited is a prominent electric vehicle manufacturer based in Shanghai, China, focusing on the premium segment of the market. Founded in 2014, the company designs, jointly manufactures, and sells smart electric vehicles, including five, six, and seven-seater SUVs. Nio is recognized for its innovative technology, including battery swapping and autonomous driving features, which enhance user experience. Its model lineup includes the ES8, a high-performance seven-seater SUV launched in 2018, the ES6 five-seater SUV, and the EC6 electric coupe SUV. The company also provides a range of charging solutions, such as home charging, battery swapping services, and mobile charging options, alongside value-added services like insurance and maintenance. In addition to its electric vehicle offerings, Nio collaborates with organizations like Mobileye N.V. to advance its technology. As of 2023, Nio has sold over 160,000 electric vehicles, capturing approximately 2% of the new energy vehicle market in China.

Nio

Series A in 2015
Nio Limited is a prominent electric vehicle manufacturer based in Shanghai, China, focusing on the premium segment of the market. Founded in 2014, the company designs, jointly manufactures, and sells smart electric vehicles, including five, six, and seven-seater SUVs. Nio is recognized for its innovative technology, including battery swapping and autonomous driving features, which enhance user experience. Its model lineup includes the ES8, a high-performance seven-seater SUV launched in 2018, the ES6 five-seater SUV, and the EC6 electric coupe SUV. The company also provides a range of charging solutions, such as home charging, battery swapping services, and mobile charging options, alongside value-added services like insurance and maintenance. In addition to its electric vehicle offerings, Nio collaborates with organizations like Mobileye N.V. to advance its technology. As of 2023, Nio has sold over 160,000 electric vehicles, capturing approximately 2% of the new energy vehicle market in China.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.